Recurrent disease-activity rebound in a patient with multiple sclerosis after natalizumab discontinuations for pregnancy planning

Mult Scler. 2016 Oct;22(11):1506-1508. doi: 10.1177/1352458513492246. Epub 2013 Jun 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Brain / pathology*
  • Chronic Disease
  • Female
  • Humans
  • Multiple Sclerosis / drug therapy*
  • Natalizumab / therapeutic use*
  • Pregnancy
  • Recurrence
  • Treatment Outcome

Substances

  • Natalizumab